文献速递胸部技术与安全USCT

COVID-19 危重症康复患者残余肺损伤的前瞻性纵向床旁肺超声研究

Residual Lung Injury in Patients Recovering From COVID-19 Critical Illness: A Prospective Longitudinal Point-of-Care Lung Ultrasound Study.
PubMed 文献 · J Ultrasound Med · 2020-11-13

研究纳入 171 例 COVID-19 重症监护病房患者,用床旁肺超声(POCUS)在住院期间及出院后 4 个月内纵向评估肺部病变。随访中将 POCUS 与临床和实验室参数整合进半定量 Riyadh 残余肺损伤量表,预测间质性肺病的敏感度为 0.82、特异度为 0.91;肺动脉高压和间质性肺病(非特异性间质性肺炎)患病率分别为 7% 和 11.8%。作者认为 POCUS 能够监测出院后重症 COVID-19 肺炎的演变,支持将其纳入残余肺损伤的临床预测模型。

要点

  • 随访期 POCUS 整合临床和实验室参数的 Riyadh 残余肺损伤量表预测间质性肺病敏感度 0.82、特异度 0.91。
  • 死亡者较存活者肺部异常(B 线、胸膜线不规则、实变)发生率增高(p < .05)。
  • 存活者出院后 4 个月内可检出残余肺损伤,肺动脉高压和间质性肺病患病率分别为 7% 和 11.8%。

关键影像表现/征象

  • 死亡者较存活者肺部异常(B 线、胸膜线不规则和实变)发生率增高(p < .05)。
  • 存活者出院后 4 个月内经 POCUS 可检出残余肺损伤表现。
  • 症状性存活者经胸部高分辨率 CT 排除间质性肺病,检出非特异性间质性肺炎。

诊断标准与关键数值

  • 随访期 POCUS 与临床和实验室参数整合的半定量 Riyadh 残余肺损伤量表预测间质性肺病:敏感度 0.82(95% CI:0.76-0.89),特异度 0.91(95% CI:0.94-0.95)。
  • 死亡预测因素:淋巴细胞减少 HR 0.88(95% CI:0.68-0.96,p = .048);乳酸升高 HR 1.17(95% CI:0.94-1.46,p = 0.049);D-二聚体 HR 1.21(95% CI:1.03-1.44,p = .03)。
  • 肺动脉高压患病率 7%,间质性肺病(非特异性间质性肺炎)患病率 11.8%。

临床应用与阅片要点

  • 对 COVID-19 重症康复者可用 POCUS 纵向观察 B 线、胸膜线不规则和实变等残余肺损伤征象。
  • 可将 POCUS 所见与临床和实验室参数整合进 Riyadh 残余肺损伤量表,用于预测间质性肺病。
  • 对症状性存活者可用胸部高分辨率 CT 排除间质性肺病、用胸部 CT 血管造影和超声心动图排除肺动脉高压。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

UNLABELLED: Scarce data exist regarding the natural history of lung lesions detected on ultrasound in those who survive severe COVID-19 pneumonia.

OBJECTIVE: We performed a prospective analysis of point-of-care ultrasound (POCUS) findings in critically ill COVID-19 patients during and after hospitalization.

METHODS: We enrolled 171 COVID-19 intensive care unit patients. POCUS of the lungs was performed with phased array (2-4 MHz), convex (2-6 MHz) and linear (10-15 MHz) transducers, scanning 12 lung areas. Chest computed tomography angiography was performed to exclude suspected pulmonary embolism. Survivors were clinically and sonographically evaluated during a 4 month period for evidence of residual lung injury. Chest computed tomography angiography and echocardiography were used to exclude pulmonary hypertension (PH) and chest high-resolution-computed-tomography to exclude interstitial lung disease (ILD) in symptomatic survivors.

RESULTS: Cox regression analysis showed that lymphocytopenia (hazard ratio [HR]: 0.88, 95% confidence intervals [CI]: 0.68-0.96, p = .048), increased lactate (HR: 1.17, 95% CI: 0.94-1.46, p = 0.049), and D-dimers (HR: 1.21, 95% CI: 1.03-1.44, p = .03) were mortality predictors. Non-survivors had increased incidence of pulmonary abnormalities (B-lines, pleural line irregularities, and consolidations) compared to survivors (p < .05). During follow-up, POCUS with clinical and laboratory parameters integrated in the semi-quantitative Riyadh-Residual-Lung-Injury scale had sensitivity of 0.82 (95% CI: 0.76-0.89) and specificity of 0.91 (95% CI: 0.94-0.95) in predicting ILD. The prevalence of PH and ILD (non-specific-interstitial-pneumonia) was 7% and 11.8%, respectively.

CONCLUSION: POCUS showed ability to monitor the evolution of severe COVID-19 pneumonia after hospital discharge, supporting its integration in clinical predictive models of residual lung injury.

来源:J Ultrasound Med,查看原文。版权归原作者所有。

引用

  1. Alharthy A, Abuhamdah M, Balhamar A, et al. Residual Lung Injury in Patients Recovering From COVID-19 Critical Illness: A Prospective Longitudinal Point-of-Care Lung Ultrasound Study. J Ultrasound Med. 2020. PMID: 33185316. doi:10.1002/jum.15563

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。